JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB271396

重组人 Cbl-c 蛋白 (DDDDK tag N-Terminus)

Recombinant Human Cbl-c protein (DDDDK tag N-Terminus)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human Cbl-c protein (DDDDK tag N-Terminus) is a Human Fragment protein, in the 11 to 404 aa range, expressed in HEK 293 cells, with >90%, suitable for SDS-PAGE.

查看别名

CBL3, RNF57, CBLC, E3 ubiquitin-protein ligase CBL-C, RING finger protein 57, RING-type E3 ubiquitin transferase CBL-C, SH3-binding protein CBL-3, SH3-binding protein CBL-C, Signal transduction protein CBL-C

1 Images
SDS-PAGE - Recombinant Human Cbl-c protein (DDDDK tag N-Terminus) (AB271396)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human Cbl-c protein (DDDDK tag N-Terminus) (AB271396)

SDS-PAGE analysis of ab271396.

关键信息

纯度

>90% SDS-PAGE

表达系统

HEK 293 cells

标签

DDDDK tag N-Terminus

应用

SDS-PAGE

applications

生物活性

No

访问

Q9ULV8

不含动物源

No

不含载体蛋白

No

种属

Human

存储溶液

pH: 8 Constituents: 20% Glycerol (glycerin, glycerine), 0.64% Sodium chloride, 0.63% Tris HCl, 0.04% Sorbitan monolaurate, ethoxylated, 0.02% Potassium chloride

storage-buffer

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

序列信息

[{"sequence":"QWEEARALGRAVRMLQRLEEQCVDPRLSVSPPSLRDLLPRTAQLLREVAHSRRAAGGGGPGGPGGSGDFLLIYLANLEAKSRQVAALLPPRGRRSANDELFRAGSRLRRQLAKLAIIFSHMHAELHALFPGGKYCGHMYQLTKAPAHTFWRESCGARCVLPWAEFESLLGTCHPVEPGCTALALRTTIDLTCSGHVSIFEFDVFTRLFQPWPTLLKNWQLLAVNHPGYMAFLTYDEVQERLQACRDKPGSYIFRPSCTRLGQWAIGYVSSDGSILQTIPANKPLSQVLLEGQKDGFYLYPDGKTHNPDLTELGQAEPQQRIHVSEEQLQLYWAMDSTFELCKICAESNKDVKIEPCGHLLCSCCLAAWQHSDSQTCPFCRCEIKGWEAVSIYQF","proteinLength":"Fragment","predictedMolecularWeight":"45 kDa","actualMolecularWeight":null,"aminoAcidEnd":404,"aminoAcidStart":11,"nature":"Recombinant","expressionSystem":"HEK 293 cells","accessionNumber":"Q9ULV8","tags":[{"tag":"DDDDK","terminus":"N-Terminus"}]}]

性能和储存信息

运输条件
Dry Ice
推荐的短期储存条件
-80°C
推荐的长期储存条件
-80°C
储存信息
Avoid freeze / thaw cycle
False

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Cbl-c also known as Casitas B-lineage lymphoma protein C is a member of the Cbl family of ubiquitin ligases. This protein has an approximate mass of 56 kDa and is expressed in various tissues including skeletal muscle and the uterus. Cbl-c functions as an E3 ubiquitin-protein ligase which means it tags target proteins for degradation by the proteasome. By doing so it regulates protein turnover and maintains cellular protein balance.
Biological function summary

Cbl-c interacts with signaling complexes and modulates signal transduction pathways. It participates in processes such as negative regulation of tyrosine kinase signaling. Cbl-c operates alongside other proteins in the Cbl family including Cbl and Cbl-b to downregulate signaling through ubiquitination. It plays a significant role in the regulation of cellular growth and differentiation by targeting specific proteins for degradation.

Pathways

Cbl-c interacts with cellular signaling mechanisms involved in the regulation of growth and cellular response. Cbl-c is an important component of pathways like the Epidermal Growth Factor Receptor (EGFR) signaling pathway and the Insulin signaling pathway. Through these pathways Cbl-c also interacts with receptor tyrosine kinases such as EGFR and insulin receptors impacting cellular processes like proliferation migration and apoptosis.

Mutations or dysregulation of Cbl-c have associations with tumor progression and metabolic disorders. Cancer and insulin resistance are two conditions in which alterations in Cbl-c function contribute to disease pathology. Interactions with proteins such as EGFR and insulin receptor through these disorders highlight Cbl-c’s involvement in critical regulatory networks impacting human health.

特殊说明

形式

Liquid

常规信息

功能

Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival.

翻译后修饰

Phosphorylated on multiple tyrosine residues by SRC. Isoform 1, but not isoform 2, is phosphorylated on tyrosines by EGFR.. Autoubiquitinated when phosphorylated at Tyr-341, enhanced by SRC; suggesting proteasomal degradation.

产品实验方案

靶点信息

Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival.
See full target information CBLC

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com